|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Alberta Cancer Board |
|---|---|
| Information provided by: | Alberta Cancer Board |
| ClinicalTrials.gov Identifier: | NCT00351572 |
Purpose
This study will determine whether a new diagnostic test called the Cell Search Assay can detect circulating colon cancer cells in patients who have had surgery for colon cancer and had visible cancer removed. Other parts of the study will look at whether the presence of the circulating tumor cells in blood predicts whether a patient will have their colong cancer return.
| Condition | Intervention |
|---|---|
|
Colon Cancer |
Procedure: Cell Search Assay |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Michael Sawyer, MD | 780-432-8248 | michsawy@cancerboard.ab.ca |
| Canada, Alberta | |
| Cross Cancer Institute | Recruiting |
| Edmonton, Alberta, Canada, T6G 1Z2 | |
| Contact: Clinical Research Unit 780-989-8152 clinical_trials_cci@cancerboard.ab.ca | |
| Principal Investigator: Michael Sawyer, MD | |
| Principal Investigator: | Michael Sawyer, MD | Alberta Cancer Board |
More Information
| Study ID Numbers: | GI-5-0055 |
| Study First Received: | July 11, 2006 |
| Last Updated: | September 22, 2008 |
| ClinicalTrials.gov Identifier: | NCT00351572 |
| Health Authority: | Canada: Health Canada |
|
colon cancer |
|
Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Colonic Diseases Gastrointestinal Neoplasms |
Intestinal Diseases Colonic Neoplasms Intestinal Neoplasms Colorectal Neoplasms |
|
Neoplasms Neoplasms by Site |
